User profiles for Eldon Spackman

Eldon Spackman

University of Calgary
Verified email at ucalgary.ca
Cited by 4648

[HTML][HTML] Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.

…, S Martin, M Soares, N Rice, E Spackman… - Health Technology …, 2015 - ncbi.nlm.nih.gov
BACKGROUND Cost-effectiveness analysis involves the comparison of the incremental cost-effectiveness
ratio of a new technology, which is more costly than existing alternatives, with …

The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial

…, I Walker, K Fijnvandraat, M Kirby-Allen, E Spackman… - The Lancet, 2013 - thelancet.com
Background No consensus exists on whether preoperative blood transfusions are beneficial
in patients with sickle-cell disease. We assessed whether perioperative complication rates …

[HTML][HTML] Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the prostate MR …

R Faria, MO Soares, E Spackman, HU Ahmed… - European urology, 2018 - Elsevier
Background The current recommendation of using transrectal ultrasound-guided biopsy (TRUSB)
to diagnose prostate cancer misses clinically significant (CS) cancers. More sensitive …

[HTML][HTML] Acupuncture and counselling for depression in primary care: a randomised controlled trial

…, S Perren, M Sculpher, E Spackman… - PLoS …, 2013 - journals.plos.org
Background Depression is a significant cause of morbidity. Many patients have communicated
an interest in non-pharmacological therapies to their general practitioners. Systematic …

Bidirectional citation searching to completion: an exploration of literature searching methods

S Hinde, E Spackman - Pharmacoeconomics, 2015 - Springer
Literature reviews underpin the majority of research projects in the health sciences, and yet
relatively little analysis has been published as to the most appropriate method to identify …

Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of …

…, L Bojke, S Griffin, C McKenna, M Soares, E Spackman… - 2012 - bura.brunel.ac.uk
Background: The general issue of balancing the value of evidence about the performance of
a technology and the value of access to a technology can be seen as central to a number of …

Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation

…, G Jhuti, S Rice, E Spackman… - Health technology …, 2016 - eprints.whiterose.ac.uk
Background: Tumour necrosis factor (TNF)-α inhibitors (anti-TNFs) are typically used when
the inflammatory rheumatologic diseases ankylosing spondylitis (AS) and non-radiographic …

[HTML][HTML] Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.

…, M Winkler, M Soares, E Spackman… - Health technology …, 2018 - ncbi.nlm.nih.gov
BACKGROUND Men with suspected prostate cancer usually undergo transrectal ultrasound
(TRUS)-guided prostate biopsy. TRUS-guided biopsy can cause side effects and has …

[HTML][HTML] The adverse health effects and harms related to marijuana use: an overview review

KA Memedovich, LE Dowsett, E Spackman… - … Open Access Journal, 2018 - cmajopen.ca
Background With impending marijuana legislation in Canada, a broad understanding of the
harms associated with marijuana use is needed to inform the clinical community and public, …

[HTML][HTML] Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis

N Iragorri, E Spackman - Public health reviews, 2018 - Springer
Background Screening is an important part of preventive medicine. Ideally, screening tools
identify patients early enough to provide treatment and avoid or reduce symptoms and other …